On October 1, 2026, the court-appointed administrator in the national AFFF multidistrict litigation posted public notice of four proposed class settlements totaling $149.075 million for U.S. public water systems with PFAS-impacted drinking water sources. The settlements, pending before Judge Richard M. Gergel in the U.S. District Court for the District of South Carolina, resolve claims against Carrier Global Corporation ($129.2 million), Archroma U.S. ($14 million), Amerex Corporation ($4 million), and Nation Ford Chemical Company ($1.875 million). All four defendants deny liability. Eligible systems have until November 23, 2026 to object and until December 22, 2026 to request exclusion; a final fairness hearing is set for January 15, 2027.
Most coverage has framed this as a “utilities could get paid” story. For finance leaders at self-insured water utilities and the public-entity pools that back them, it is something else: a two-month window in which an open, long-tail environmental liability either becomes a known, allocable payment or stays on the books as an uncertain claim against a shrinking set of non-settling defendants.
A second tranche, not a rerun
This $149 million sits on top of a much larger wave of AFFF settlements already finalized. In March 2024, Judge Gergel granted final approval to 3M’s settlement of $10.5 billion to $12.5 billion, with payments to participating public water providers spread over 13 years and the first payouts beginning in the third quarter of 2024. A parallel settlement from DuPont, Chemours, and Corteva added $1.185 billion, bringing the combined pool to roughly $13.6 billion.
Those earlier programs have largely closed their claim windows. The DuPont fund’s treatment-cost deadline passed June 30, 2026, the 3M fund’s followed July 31, 2026, and the Special Needs Funds attached to both closed August 1, 2026. Systems that missed those deadlines forfeited those portions of their claims permanently, and because participation carried a release, they can no longer sue the settling manufacturers over PFAS in drinking water.
The new Carrier, Archroma, Amerex, and Nation Ford settlements are distinct dollars from distinct defendants. That distinction is exactly where a claims operation can stumble: a utility that already reserved, filed, and closed out its 3M and DuPont claims risks treating this notice as duplicate exposure already resolved, when it is incremental recovery against separate manufacturers.
Who it affects
The proposed classes generally cover active U.S. public water systems with one or more PFAS-impacted water sources as of July 31, 2026, plus systems required to test under EPA’s Fifth Unregulated Contaminant Monitoring Rule (UCMR 5) or serving more than 3,300 people. Private household wells are excluded, as are certain state-owned systems. In practice, the affected population is municipal and special-district water utilities, many of which are self-insured or insured through public-entity pools and joint powers authorities. If your entity runs a water department, a water authority, or a regional utility, this notice reaches you. Systems that previously submitted claim information in the earlier rounds may resubmit or update their claims.
The reserve mechanism: determinability, not frequency or severity
This development does not move claim frequency or severity. It moves two other levers.
First, case reserve determinability. A settlement allocation, once approved and quantified under the court’s allocation procedures, is a determinable amount. A utility that stays in the class can pull its case reserve for PFAS remediation cost recovery from an estimate range to a hard number, net of the legal fees and administration costs the notices flag as reductions to the distributed funds. A utility that excludes itself to litigate separately keeps an open case reserve against defendants who deny liability, with no payment schedule and no allocation formula.
Second, tail length. The 3M settlement pays out over 13 years, which means even settled claims carry a long disbursement tail. The new tranche’s payment mechanics are not yet published in final form; the January 15, 2027 fairness hearing will determine approval and, with it, the allocation and payment timing. Until then, any reserve tied to this settlement is a contingent receivable, not cash. And litigation continues against non-settling AFFF defendants, so a utility’s total PFAS exposure is not resolved by any single tranche; claims against remaining defendants should be reserved independently rather than bundled into the settled population.
One coding note matters for the development triangle: these defendants deny liability while settling. A settlement is not an adjudicated loss, and the recovery should be coded as a settlement recovery credit against the environmental remediation loss, not as a court-ordered judgment. Misclassifying it distorts the recovery pattern your actuary fits.
Where this shows up in your reserves
Open last quarter’s actuarial report and look at the general liability or environmental line for the public-entity program, specifically the recovery and subrogation section. If your utility carried a gross reserve for PFAS treatment costs with an estimated recovery from AFFF manufacturers, check whether that estimated recovery was built from the 3M and DuPont settlement data alone. If so, the estimate likely understates total recoveries now that a second defendant group has settled, and it also embeds a development pattern from large, early-settling manufacturers that may not fit smaller, later-settling defendants. For pools, the same question sits at the member level: which member utilities are in the class, which have PFAS detections that qualify under UCMR 5, and which have open claims against non-settling defendants that need separate case reserves. Our public entity general liability IBNR primer covers how these long-tail environmental exposures behave in pool triangles, and the tail factor discussion for captives applies directly to a 13-year payout structure.
What this means for your next review
Put the settlement classification on the agenda for your next reserve study or interim monitoring meeting, ahead of the November 23 objection deadline. The decision your counsel makes on opt-in, objection, or exclusion determines which reserve treatment applies, and your actuary cannot pick the right one without knowing the litigation posture. If you want a structured checklist for the broader warning signs, the leading indicators of adverse development include exactly this pattern: recoveries assumed but not yet documented.
Decision-maker checklist
- Confirm with counsel by mid-October whether your system meets the eligibility criteria, including UCMR 5 testing status and the 3,300-person service threshold, before the November 23 objection deadline.
- Ask your actuary how the case reserve for this specific PFAS claim changes under each of the three paths: accept the allocation, object, or exclude and litigate separately.
- Verify that any estimated AFFF recovery in your current reserves reflects only the 3M and DuPont settlements, and book this tranche as incremental, not duplicative.
- Confirm with your claims team that open claims against non-settling AFFF defendants are reserved independently rather than netted against settled exposure.
- If you already filed in earlier rounds, resubmit or update claim information with the administrator; prior filings do not automatically carry into these classes.
- Calendar the January 15, 2027 fairness hearing, and revisit the reserve treatment once the court rules on approval and allocation.
Watch next: whether the January fairness hearing clears this tranche quickly, and whether the remaining non-settling AFFF defendants face comparable settlement pressure once it does. Each additional settling defendant converts another slice of uncertain mass tort tail into a determinable, but slow-paying, receivable.
An independent reserve review brings a second pair of eyes that’s free of the TPA’s or fronting carrier’s incentive structure. We’re working on a directory of independent reviewing actuaries. If you’d like to be considered, get in touch.
Sources
- Underground Infrastructure: Proposed $149 million PFAS settlements could benefit U.S. water utilities (October 2, 2026)
- AboutLawsuits.com: 3M PFAS Settlement With Public Water Providers Receives Final Approval By MDL Judge (April 4, 2024)
- Florida Tap Report: Proposed $149 million PFAS settlements: what Florida water utilities should know (October 2, 2026)
- EPA: Fifth Unregulated Contaminant Monitoring Rule (UCMR 5)